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Abstract
Objectives—To evaluate the neurodevelopmental outcomes of very preterm (<30 weeks) infants
who underwent tracheostomy.
Study design—Retrospective cohort study from 16 centers of the NICHD Neonatal Research
Network over 10 years (2001-2011). Infants who survived to at least 36 weeks (N=8,683),
including 304 infants with tracheostomies, were studied. Primary outcome was death or
neurodevelopmental impairment (NDI, a composite of one or more of: developmental delay,
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neurologic impairment, profound hearing loss, severe visual impairment) at a corrected age of
18-22 months. Outcomes were compared using multiple logistic regression. We assessed impact
of timing, by comparing outcomes of infants who underwent tracheostomy before and after 120
days of life.
Results—Tracheostomies were associated with all neonatal morbidities examined, and with most
adverse neurodevelopmental outcomes. Death or NDI occurred in 83% of infants with
tracheostomies and 40% of those without [odds ratio (OR) adjusted for center 7.0 (95%CI,
5.2-9.5)]. After adjustment for potential confounders, odds of death or NDI remained higher [OR
3.3 (95%CI, 2.4-4.6)], but odds of death alone were lower [OR 0.4 (95%CI, 0.3-0.7)], among
infants with tracheostomies. Death or NDI was lower in infants who received their tracheostomies
before, rather than after, 120 days of life [adjusted OR 0.5 (95%CI, 0.3-0.9)].
Conclusions—Tracheostomy in preterm infants is associated with adverse developmental
outcomes, and cannot mitigate the significant risk associated with many complications of
prematurity. These data may inform counseling about tracheostomy in this vulnerable population.
Keywords
newborn; very low birth weight infant; neurodevelopmental impairment; tracheotomy;
bronchopulmonary dysplasia; prematurity
Decisions about whether and when to place a tracheostomy in preterm infants who require
prolonged ventilation or who have airway abnormalities are challenging. Most
tracheostomies in children are performed in infants less than 12 months of age.(1) A few
small studies document the incidence of mortality and airway morbidity after tracheostomy
in young children.(2-4) Even more limited data are published on longer-term morbidities
and neurodevelopmental outcomes.(5-8) The most recent large, single-center cohort study of
165 infants with tracheostomies reported 3-year survival of 91%, but developmental delays
in 64%. This study did not detail the timing or content of the developmental evaluations.(8)
Very preterm infants have a high baseline risk for adverse long-term outcomes, and severe
lung disease substantially increases this risk.(9, 10) It is unknown whether tracheostomy is
independently associated with an increased risk for adverse outcomes in preterm infants.
Moreover, optimal timing for tracheostomy is unknown.(11, 12) Such information could
help inform clinicians when making decisions with families about the timing of
tracheostomy placement, and planning for the care of these children throughout childhood.
We performed a cohort study to evaluate the outcomes of very preterm infants undergoing
tracheostomy in the NICHD Neonatal Research Network (NRN) over a 10-year period. Our
goals were to report the developmental outcomes of infants with tracheostomies who were
evaluated in follow-up at 18-22 months corrected age, in comparison with the rest of the
population of very preterm infants; and to evaluate whether timing of tracheostomy is
related to outcomes.
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Methods
The NRN uses a predefined protocol which prospectively collects medical and
developmental follow-up data at 18-22 months corrected age on all infants born with birth
weight 401-1000 grams (if born before 1/1/2008) or before 27 weeks gestation (if born on or
after 1/1/2008).(13) The same protocol is used to collect follow-up data about children of
any gestational age who are enrolled in an NRN clinical trial requiring neurodevelopmental
follow-up. In the current analyses we evaluated outcomes of the cohort of infants who were
born before 30 weeks of gestation, who survived to at least 36 weeks postmenstrual age and
who were eligible for follow-up at one of the 16 centers that participated in the NRN from
2001 to 2011. Institutional Review Boards at each study center approved the collection of
data during both the initial hospitalization and neonatal follow-up.
The primary outcome was a composite of two important competing outcomes: death or
neurodevelopmental impairment (NDI) at 18-22 months. Standard definitions of NDI were
used: NDI consisted of neurologic impairment, developmental delay, or visual or hearing
impairment.(14, 15) By expert consensus, the definition of NDI evolved after the Bayley
Scales of Infant Development-II were replaced by the Bayley-III.(16-19) For children born
before 1/1/2006, cutoffs for NDI were: neurologic impairment – moderate to severe cerebral
palsy with Gross Motor Function Classification Scale (GMFCS) level of 2 or higher;
developmental delay – Bayley-II Mental or Psychomotor Development Index (MDI or PDI)
<70; visual impairment – <20/200 bilaterally; hearing impairment – bilateral amplification
for permanent hearing loss.(20) Children born after 1/1/2006 were tested with the Bayley
Scales of Infant Development-III. Cutoffs for NDI were: neurologic impairment – moderate
to severe cerebral palsy; developmental delay: Bayley-III Cognitive or Motor score <85;
visual impairment – limited with correction or blindness in one or both eyes; hearing
impairment – permanent hearing loss that does not permit child to understand directions and
communicate. An infant was considered to have NDI if one or more of the components of
the composite outcome were known to be present, or unaffected if no component was
present. If one or more components of NDI were missing and no component could be
confirmed as abnormal, the primary outcome was deemed missing. To ensure that
differences in primary outcomes could not be ascribed to the temporal change in testing
regimens, a separate analysis was performed by time period of neurodevelopmental testing.
Secondary outcomes were the individual components of NDI, relationship between timing
of tracheostomy and outcomes, results of the Brief Infant/Toddler Social and Emotional
Assessment (BITSEA) scale and, for infants tested with the Bayley III, language scores with
receptive and expressive language subscales.(17, 21, 22)
Bronchopulmonary dysplasia (BPD) was defined as oxygen use at 36 weeks postmenstrual
age. Both the presence and the severity of BPD are independently associated with cognitive
impairment.(23, 24) Therefore, to measure the severity of BPD, we described “prolonged
ventilation” as receipt of mechanical ventilation for more than the 75th percentile (43 days).
Brain injury was defined as intraparenchymal hemorrhage [Grade 4 intraventricular
hemorrhage (IVH)], IVH with ventricular enlargement (Grade 3 IVH), or cystic
periventricular leukomalacia on cranial ultrasound in the first 28 days. Severe retinopathy of
DeMauro et al. Page 4
J Pediatr. Author manuscript; available in PMC 2015 June 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
prematurity (ROP) was defined as stage 3 or higher or any retinopathy that required
treatment. Necrotizing enterocolitis (NEC) was defined as stage II or III, based on the
modified Bell's staging criteria.(25) Infants were classified with malformations or
syndromes if they were diagnosed with any major malformations, chromosomal
abnormalities, or other syndromes with multi-organ involvement at any point during the
hospitalization. Our data set allowed determination of “earlier” tracheostomy if infants
received a tracheostomy prior to 120 days of life or “later” tracheostomy if they were
subsequently coded as having a tracheostomy at the time of follow-up. All other infants
were classified in the “no tracheostomy” group.
Statistical Analyses
We used traditional bivariate tests to compare baseline demographics and neonatal
morbidities among infants with and without tracheostomies. We used t-tests for normally
distributed continuous data, Poisson models for count data such as number of
rehospitalizations, and chi-squared tests for dichotomous data. Odds of death or NDI, based
on the presence of a tracheostomy at any time before follow-up, were evaluated with logistic
regression. Regression models were first adjusted for center as a fixed effect. The analysis
was then repeated with center and several additional pre-specified potential confounding
variables. All of these variables were known to be independently correlated with survival or
long-term developmental outcome. Variables fell into two groups: (1) baseline factors –
birth weight (as a continuous variable), sex, antenatal steroid exposure, race, presence of
syndromes or major malformations, and (2) neonatal morbidities (as defined above) – brain
injury, sepsis, NEC, severe ROP, surgical ligation of patent ductus arteriosus (PDA), and
BPD. To ensure that the above described changes in the definition of NDI did not lead to
spurious associations, time period was included in all models.
The same models were used to compare components of the primary outcome, Bayley-III
language scores, and other developmental outcomes between the groups and to generate
risk-adjusted probabilities. Subgroup analyses were performed to evaluate the effect of
changing definitions of NDI on the primary outcome.
Finally, we planned to evaluate the effect of “Earlier” versus “Later” tracheostomy on
outcome. Our database does not include procedure dates, but does indicate whether critical
events (such as tracheostomy) occurred before or after 120 days of life. Therefore, we
compared outcomes of patients who underwent tracheostomy prior to 120 days of life
(“Earlier”) with outcomes of those who underwent tracheostomy at any time between 120
days and follow-up (“Later”).
Analyses were performed with SAS version 9.3 and p<0.05 was considered significant. No
adjustments were made for multiple comparisons in this exploratory observational study.
Results
Over the study period (2001-2011), 10,128 children were born before 30 weeks gestation,
survived to at least 36 weeks postmenstrual age, and were eligible for neonatal follow-up at
18-22 months corrected age in 16 NRN centers. We excluded 1,445 (14%) children because
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of missing data on the primary outcome, of whom 29 (2.0%) had tracheostomies. The
remaining 8,683 children included 304 children (3.5%) with tracheostomies (Table I).
Infants who underwent tracheostomy had lower average birth weight and gestational age and
were more likely to be male and have a congenital anomaly. Infants with tracheostomies had
higher incidence of all in-hospital morbidities than those without tracheostomies (Table I).
There was no significant change in incidence of tracheostomy over the 10 years of this study
(Wald χ2 p=0.29). The proportion of children undergoing tracheostomy varied significantly
across the 16 participating centers from 1% to 10% (Wald χ2 p<0.001), likely reflecting
differing referral and practice patterns. The average corrected age at which developmental
testing was performed in survivors was the same in the two groups [median 19 months,
interquartile range (16-22), p=0.27].
Primary Outcome
Children with tracheostomies had significantly higher risk of the primary composite
outcome of death or NDI and of all of the components of NDI (Table II) than children
without tracheostomies. In an attempt to adjust for risk factors other than tracheostomy, we
performed pre-specified analyses adjusted for 15 factors. Each of these is known to be
associated with both risk for tracheostomy and risk for adverse neurodevelopmental
outcomes, as described above. After adjustment, prevalence of the primary outcome of death
or NDI, NDI, and the components of NDI remained substantially higher in children with
tracheostomies than in those without tracheostomies (Table II). The “fully adjusted” odds
ratio (OR) of death or NDI in children with tracheostomies, compared with those without,
was 3.3 (95% CI, 2.4-4.6), and the fully adjusted odds ratio of NDI in survivors with
tracheostomies, compared to those without, was 4.0 (95% CI, 2.9-5.5). The Figure
summarizes graphically the elevated risk-adjusted probabilities of adverse outcomes in
children with tracheostomies compared with those without tracheostomies.
After adjusting only for center, there was no difference between the groups in risk of death
between 36 weeks postmenstrual age and 18-22 months (Table II). However, in the fully
risk-adjusted analyses, mortality was significantly lower in children with tracheostomies. To
explore this unexpected result, post-hoc analysis in the full model, suggested that this
difference was completely mediated by the inclusion of BPD and prolonged ventilation. One
interpretation is that children with BPD who did not have tracheostomies had an increased
risk of death.
Secondary Outcomes
Most other secondary developmental outcomes were significantly worse in the children with
tracheostomies (Table III). Although tracheostomy is expected to be associated with delays
in expressive language, we observed a similar delay in receptive language skills. Only the
“problem score” of the BITSEA was similar in the two groups, indicating that 18-22 month
old children with tracheostomies are not at increased risk for social-emotional/behavioral
problems. Nonetheless, children with tracheostomies appear to have higher risk for delays in
social-emotional competence.
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When definitions of NDI changed from Bayley-II to Bayley-III, there was a statistically
significant decrease in the proportion of children who were classified as having NDI; 38%
(2205/5803) of children tested with the Bayley-II were classified as having NDI compared
with 36% (833/2314) of children tested with the Bayley-III (p=0.019). However, despite this
difference, the change in definition of NDI did not reduce the highly significant association
between tracheostomy and NDI (p<0.001).
Due to the limitations of our data set, the timing of tracheostomy could only be evaluated by
whether it occurred before (“Earlier” n=132) or after (“Later” n=172) 120 days of life. In
pre-specified analyses, as compared with all children without tracheostomy, fully adjusted
odds ratio of death or NDI for children who underwent Earlier tracheostomy was 2.3 (95%
CI, 1.5-3.5), whereas it was 4.7 (95% CI, 2.9-7.4) for children who underwent Later
tracheostomy. The fully adjusted odds ratio for death or NDI in children who received
Earlier tracheostomy, when compared with those who received Later tracheostomy, was 0.5
(95% CI, 0.3-0.9).
Discussion
This retrospective study of prospectively collected data cannot establish causality, but
merely suggest plausible associations. However, this cohort is unique in several ways. We
evaluated mortality and neurodevelopmental outcomes at 18-22 months corrected age in
children who were born at less than 30 weeks gestation and underwent tracheostomy
placement. Prior smaller, mostly single center studies of children with tracheostomies did
not include comparison groups without tracheostomies. In contrast, our large data set was
collected in a standard protocol at 16 sites over a 10-year period and includes comparison
with the larger population of preterm infants without tracheostomies.
In our cohort, tracheostomy was associated with a significantly increased risk for the
composite primary outcome of death or NDI. Because of the many known risk factors for
adverse developmental outcome and survival in preterms, we performed a number of a-
priori risk adjustments. Even after adjusting for 17 factors predictive of adverse outcome,
children with tracheostomies still had significantly increased odds of adverse developmental
outcomes. Although tracheostomy might itself put children at risk for poor outcomes, such a
causal relationship is less likely than a non-causal association between tracheostomy and
significantly increased risk for poor outcome. It is more likely that we have not fully
controlled for confounding by indication, despite a 17 factor adjustment. It is likely that the
need for tracheostomy itself defines a risk for adverse outcome that is not wholly captured
by the risk factors included. In other words, tracheostomy may be a marker for risk. These
limitations of our statistical models do not change the importance of our results. Clinicians
considering a tracheostomy for an individual patient could supplement clinical status and
history with these data to help parents grasp potential long term outcomes.
Although only a minority of preterm infants ultimately undergo tracheostomy placement, the
paucity of relevant literature makes decisions about this procedure very challenging. Reports
of complications following pediatric and infant tracheostomy have almost exclusively
described indications, mortality, and airway related complications.(26-31) A few older
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studies reported intellectual disabilities and language delays in children requiring
tracheostomies.(5, 6, 32-34) In 1974, children who received tracheostomies early in life
were reported to be “withdrawn in character and of poor academic and recreational
standard.”(35) Singer reported developmental outcomes at an average of 5 years in a cohort
of 130 infants from 2 hospitals who received tracheostomies before 13 months of age during
1972-82.(6) Twenty-nine percent died before follow-up and 45% of survivors were
classified with mental retardation or neurological handicap. In a single-center study of 41
infants with tracheostomies, 83% required tube feedings, 97% had abnormal muscle tone,
36% had cerebral palsy, and 24% required hearing aids at a mean age of 27 months.(7)
Among those evaluated after 12 months of age, only 16% had average skills and 68% had
significant developmental delays. In a questionnaire-based study of functional status in
former very preterm infants with tracheostomies, parents reported deterioration over time,
especially in the areas of responsiveness, activity, and interpersonal functioning.(36) Finally,
a recent single-center series reported that 64% of 165 children with tracheostomies had
“some degree of developmental delay,” without defining “delay” or describing when or how
these delays were identified.(8) We undertook the current study because these existing series
cannot be generalized beyond their centers, have not adjusted for any of the known
confounders of neurodevelopmental outcome in this population, and do not contain
comparisons with children without this major complication of prematurity. Our results
support prior reports of high risk for adverse outcomes in this population, even after
consideration of multiple factors that put children at risk for poor long-term outcomes. This
study also provides estimates of the prevalence of these outcomes in preterm children with
tracheostomies. The 8% mortality that we report is lower than the mortality reported in older
studies, which report mortality as high as 59%.(2, 3, 30, 37)
Our results suggest a possible association between Earlier (<120 days) tracheostomy and
better neurodevelopmental outcomes. This result supports the work of several authors who
have recently suggested that, in older children and adults, tracheostomy placement should be
performed as soon as possible.(8, 38, 39) We speculate that while an infant awaits a
tracheostomy, the medical focus is often on strategies to enable weaning and limit
ventilator-associated lung injury. Following a tracheostomy, the focus may shift to
maximizing parent-child interaction and developmental enrichment. Furthermore, there is
often opportunity to wean off of sedating medications, which may be associated with
increased risk of NDI, after tracheostomy.(40) Importantly, severity of illness, indication for
tracheostomy, anesthetic exposure, or other factors could have influenced either the timing
of tracheostomy or developmental outcomes, leading to potential for bias. Therefore,
prospective confirmation of this temporal relationship is essential before clinicians can
confidently counsel parents toward earlier decisions about tracheostomy placement.
Long-term ventilation secondary to BPD is the most common indication for tracheostomy in
preterm infants.(5, 11, 12) Both the presence and the severity of BPD strongly influence
neurodevelopmental outcomes.(24) Because data for the “physiologic definition” of BPD
were not available for the majority of patients in the current study, we instead used oxygen
dependence at 36 weeks and prolonged mechanical ventilation as markers of the presence
and severity of lung disease.(41, 42) As expected, poor outcomes were strongly correlated
with both of these measures. Unexpectedly, the observed differences in the fully adjusted
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odds of mortality after 36 weeks were strongly associated with death of children with BPD
who did not undergo tracheostomy. As discussed above, it remains possible that we have not
adequately controlled for the impact of lung disease on long-term outcomes, or that
clinicians offered therapy selectively. Nonetheless, because the majority of infants who
undergo tracheostomy have severe BPD, our results remain relevant and applicable to these
children.
Comparing neurodevelopmental outcomes in children who were tested with different
editions of the Bayley Scales of Infant Development is a recent challenge in neonatal
follow-up.(18, 19) We decided a priori to use the existing NRN definitions of NDI,
recognizing that the different tests and definitions might capture slightly different outcomes.
However, both the proportion of children who were diagnosed with NDI and the association
of tracheostomy with NDI were relatively consistent over time. An additional limitation of
using the Bayley Scales of Infant Development at 18-22 months is the increased recognition
that assessments at this early time point do not predict school age functioning, except
perhaps in the most severely affected children.(43-47) Many children classified as mildly-
moderately impaired as toddlers demonstrate gains in cognitive performance when re-
evaluated at older ages.(43, 44) Unfortunately, data about school-age outcomes are not
available for this or any other large cohort of children with tracheostomies.
We acknowledge several additional limitations of this large observational study. Firstly,
attrition bias is possible because we are unable to ascertain the primary outcome in 14% of
eligible children and attrition was higher among children without tracheostomies. Selection
bias may have been introduced either by clinical decisions about which infants received
tracheostomies or by the inclusion of only survivors to 36 weeks in the current study. Lastly,
we emphasize again that we can only describe an association between the need for
tracheostomy and adverse outcomes. The child who ultimately requires tracheostomy
placement will have accumulated multiple risk factors for adverse outcome, some of which
we were able to include in our analyses and some of which must be considered unmeasured
confounders. Thus, the need for tracheostomy must suggest to clinicians that a patient's
severity of illness puts that patient at extremely high risk for adverse long-term outcomes.
In conclusion, this is the first large, multicenter study to describe the long-term
neurodevelopmental outcomes of preterm infants with tracheostomies with comparison with
the general preterm population. Tracheostomy does not mitigate the significant risk for
adverse neurodevelopment that is associated with multiple neonatal morbidities, major
malformations, or severe BPD. However, if tracheostomy is to be performed, earlier surgery
may allow opportunities for enhanced neurodevelopment. Information about the association
between tracheostomy placement and outcomes in this population may facilitate a shared
decision-making process between parents and clinicians about whether and when to pursue
tracheostomy placement.
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Figure. Risk-Adjusted Probabilities of Components of Neurodevelopmental Impairment and
Bayley Scales of Infant Development, by Tracheostomy
Error bars represent 95% confidence intervals for risk-adjusted probabilities. Probabilities
were adjusted for center, time period, birth weight, sex, antenatal steroid exposure, race,
presence of syndromes or major malformations, brain injury, sepsis, NEC, severe ROP,
surgical ligation of PDA, BPD (oxygen dependence at 36 weeks) and prolonged ventilation.
Language delay is defined as <85 (ie, >1 standard deviation below the expected mean score
of 100, on the language scale of the Bayley Scales of Infant Development-III). Neurologic
delay is defined as moderate to severe cerebral palsy with GMFCS level of 2 or higher.
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Table 1
Demographics and medical morbidities in infants with and without tracheostomies
Tracheostomy No tracheostomy P-value
Neonatal and Maternal Demographics
Male 169/304 (56) 4031/8379 (48) 0.010
Gestational age, weeks 25 [2] 26 [2] < 0.001
Birth weight, grams 717 [201] 790 [223] < 0.001
Antenatal steroids 244/303 (81) 6984/8345 (84) 0.144
1-minute Apgar 0-3 127/299 (42) 3137/8296 (38) 0.103
5-minute Apgar 0-3 36/300 (12) 719/8298 (9) 0.045
Born outside study center 26/304 (9) 718/8379 (9) 0.992
Syndromes and/or major malformations 18/304 (6) 198/8379 (2) < 0.001
Race
    Black 130/303 (43) 3644/8371 (44)
    White 121/303 (40) 3021/8371 (36) 0.183
    Hispanic 47/303 (16) 1396/8371 (17)
    Other 5/303 (2) 310/8371 (4)
Highest level of maternal education
    Less than high school 83/286 (29) 2132/8061 (26) 0.264
    High school 92/286 (32) 2409/8061 (30)
    College 111/286 (39) 3520/8061 (44)
Neonatal Morbidities
Necrotizing enterocolitis 41/303 (14) 836/8378 (10) 0.044
Brain injury 79/304 (26) 1304/8360 (16) < 0.001
Severe retinopathy of prematurity 133/301 (44) 1974/8133 (24) < 0.001
Patent ductus arteriosus ligation 95/304 (31) 1377/8377 (16) < 0.001
Bronchopulmonary dysplasia – oxygen requirement at 36 weeks 269/304 (88) 4145/8349 (50) < 0.001
Sepsis – number of episodes 1 [2] 0 [1] < 0.001
Data are displayed as n/N (%) or median [interquartile range].
Denominators may not be equal because of missing data.
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